Resultats de la cerca - Carmelo Scarpignato

Refinar resultats
  1. 1
    Piroxicam-β-Cyclodextrin: A GI Safer Piroxicam

    Piroxicam-β-Cyclodextrin: A GI Safer Piroxicam per Carmelo Scarpignato

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth

    Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth per Luigi Gatta, Carmelo Scarpignato

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?

    Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease? per Richard H. Hunt, Carmelo Scarpignato

    Publicat 2015
    Obtenir text complet
    Editorial
    Afegir a favorits
    Guardat en:
  4. 4
    Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments

    Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments per Carmelo Scarpignato, Richard H. Hunt

    Publicat 2024
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulphate based bioadhesive formulation

    Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non‐erosive reflux disease – efficacy of Esoxx, a hyaluronic acid–chondroitin sulph... per Vincenzo Savarino, Fábio Pace, Carmelo Scarpignato

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Ageusia, gastrointestinal symptoms and marked asthenia in late December. A single case report with positive SARS-Cov2 IgG in Italy

    Ageusia, gastrointestinal symptoms and marked asthenia in late December. A single case report with positive SARS-Cov2 IgG in Italy per Paolo, Caffarra, Carmelo, Scarpignato, Marcello, Maggio

    Publicat 2020
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  7. 7
    Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers

    Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers per Carmelo Scarpignato, Corrado Blandizzi, G.C. Viscomi

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Oesophageal corrosive injuries in children: a forgotten social and health challenge in developing countries

    Oesophageal corrosive injuries in children: a forgotten social and health challenge in developing countries per Sandro Contini, Alim Swarray‐Deen, Carmelo Scarpignato

    Publicat 2009
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Review article: do stimulant laxatives damage the gut? A critical analysis of current knowledge

    Review article: do stimulant laxatives damage the gut? A critical analysis of current knowledge per Peter J. Whorwell, Robert Lange, Carmelo Scarpignato

    Publicat 2024
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

    Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy per Luigi Gatta, Nimish Vakil, D. Vaira, Carmelo Scarpignato

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  11. 11
    Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression

    Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression per Carmelo Scarpignato, Luigi Gatta, Angelo Zullo, Corrado Blandizzi

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  12. 12
    Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD

    Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD per A. P. S. Hungin, Michael Molloy‐Bland, Carmelo Scarpignato

    Publicat 2018
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  13. 13
    Determinants of the short‐term gastric damage caused by NSAIDs in man

    Determinants of the short‐term gastric damage caused by NSAIDs in man per Ingvar Bjarnason, Carmelo Scarpignato, Koji Takeuchi, K. D. Rainsford

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  14. 14
    Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017

    Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017 per Carmelo Scarpignato, Giovanni Barbara, Ángel Lanas, Lisa L. Strate

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  15. 15
    Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis – an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks

    Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis – an expert consensus addressing benefits as well as gastrointestinal and cardiovascular r... per Carmelo Scarpignato, Ángel Lanas, Corrado Blandizzi, Willem F. Lems, Matthias Hermann, Richard H. Hunt

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs

    Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs per Ingvar Bjarnason, Carmelo Scarpignato, Erik Holmgren, Michael W. Olszewski, K. D. Rainsford, Ángel Lanas

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  17. 17
    Reflux related symptoms in patients with normal oesophageal exposure to acid.

    Reflux related symptoms in patients with normal oesophageal exposure to acid. per G.Y. Shi, Stanislas Bruley des Varannes, Carmelo Scarpignato, Marc Le Rhun, J. P. Galmiche

    Publicat 1995
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Impact of primary antibiotic resistance on the effectiveness of sequential therapy for <i>Helicobacter pylori</i> infection: lessons from a 5-year study on a large number of strains

    Impact of primary antibiotic resistance on the effectiveness of sequential therapy for <i>Helicobacter pylori</i> infection: lessons from a 5-year study on a large number of strain... per Luigi Gatta, Carmelo Scarpignato, Giulia Fiorini, Jonathan Belsey, Ilaria Maria Saracino, Carlo Ricci, D. Vaira

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Colonic diverticular disease

    Colonic diverticular disease per Antonio Tursi, Carmelo Scarpignato, Lisa L. Strate, Ángel Lanas, Wolfgang Kruis, Adi Lahat, Silvio Danese

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  20. 20
    Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans

    Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans per Carmelo Scarpignato, Werner Dolak, Ángel Lanas, Peter Matzneller, Cecilia Renzulli, Maria Grimaldi, Markus Zeitlinger, Ingvar Bjarnason

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: